Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Beyond live probiotics: bioactivities, mechanisms, and application perspectives of Lacticaseibacillus rhamnosus cell-free supernatants.

Created on 04 Nov 2026

Authors

Ruoyi Wu, Ke Ding, Xiaoli Wang, Chengshui Liao

Published in

World journal of microbiology & biotechnology. Volume 42. Issue 11. Nov 03, 2026. Epub Nov 03, 2026.

Abstract

Lacticaseibacillus rhamnosus is one of the most widely investigated probiotic species. Live preparations can modulate intestinal microbiota, support immune function, and ameliorate metabolic disorders. However, poor stability during processing and storage, low gastrointestinal survival, variable intestinal colonization, and potential risks in immunocompromised individuals limit the use of live preparations. Therefore, an increasing number of studies have focused on cell-free supernatant (CFS). Studies directly investigating CFS form the primary evidence base of this review. Findings from studies involving live cells, isolated components, mixed preparations, or other postbiotic materials are included only to provide preparation-specific mechanistic context. This review summarizes the active ingredients of CFS and the existing evidence regarding its antibacterial, antifungal, antibiofilm, anti-inflammatory, immunomodulatory, antioxidant, antitumor, and metabolic effects. Their underlying mechanisms will be elaborated in detail, including membrane disruption, quorum-sensing interference, modulation of nuclear factor kappa B and nuclear factor erythroid 2-related factor 2 signaling, reinforcement of epithelial barrier function, as well as regulation of gut-brain and gut-liver axes. CFS offer potentially greater stability and a lower risk of microbial translocation, supporting applications in food preservation, skin care, reproductive health, metabolic intervention, and veterinary products. Future work should combine activity-guided fractionation with metabolomics, proteomics, and standardized cross-strain evaluation, while defining formulation, dose, stability, and safety requirements. These advances are essential for developing reproducible natural antimicrobial agents and functional foods based on L. rhamnosus CFS.

PMID:
42975769
Bibliographic data and abstract were imported from PubMed on 04 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement